Search for a command to run...
<b>Background:</b> Obstructive sleep apnea (OSA) is associated with slower response speed, yet conventional severity classification based on the apnea-hypopnea index (AHI) shows limited ability to predict cognitive outcomes. The AHI aggregates distinct pathophysiological processes, including intermittent hypoxemia and sleep fragmentation. Within emerging precision sleep medicine frameworks, disentangling these mechanisms is critical for improved phenotyping and personalized risk assessment. This study aimed to replicate prior findings using a Go/No-Go Continuous Visual Attention Test (CVAT) and to identify the most informative polysomnographic predictor of attentional performance in OSA. <b>Methods:</b> In this cross-sectional study, participants underwent full-night type I polysomnography and the CVAT. After exclusions, 84 patients with OSA and 22 polysomnographically normal controls were analyzed. The sample sizes for mean differences and correlational analyses were adequate. Attentional performance was indexed by standardized reaction time (RT), referenced to a normative database (n = 1244). Within the OSA group, linear regression with backward elimination evaluated hypoxemia and sleep fragmentation metrics. <b>Results:</b> Patients with OSA demonstrated significantly slower RTs than controls (<i>p</i> = 0.005). Within OSA, the AHI was not associated with attentional performance (<i>p</i> = 0.398). In the final regression model, sleep stage shifts-reflecting sleep-wake instability-emerged as the sole independent predictor of attentional slowing (β = 0.27, <i>p</i> = 0.013), whereas all hypoxemia indices were excluded. <b>Conclusions:</b> Sleep stage instability represents a cognitive vulnerability marker in OSA, independent of respiratory events. Integrating fragmentation metrics into precision sleep medicine models may enhance individualized phenotyping, identify patients at higher neurocognitive risk, and inform targeted interventions focused on stabilizing sleep architecture rather than relying solely on the AHI.
Published in: Journal of Personalized Medicine
Volume 16, Issue 2, pp. 117-117
DOI: 10.3390/jpm16020117